4XQ-18132-63139
3 vaccinations
4 coded responses
24 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Moderna
-
2021-01-25
Registered in v-safe
-
2021-01-26
Survey response — day 14, dose 1MedDRA: Arthralgia, Chills, Fatigue, Influenza like illness, Myalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Flu-like symptoms for 5 days after vaccine, with generalized myalgia, fatigue, chills, some arthralgias, fatigue. Now fully resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
-
2021-02-09
Dose 2 — Moderna
- 2021-02-09
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Livedo reticularis, Nausea, Pre-existing disease, Raynaud's phenomenon, Reaction to previous exposure to any vaccine — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Except for the nausea, which is new, the signs and symptoms are similar to the first administration - just somewhat more severe. Also Raynauds and livido - more severe this morning than now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Livedo reticularis, Raynaud's phenomenon — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Raynauds; livido reticularis. Improved since yesterday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
-
2021-05-11
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Fatigue, Laboratory test, Pre-existing disease, Raynaud's phenomenon, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Continuing Raynauds and chillblains. Sicca syndrome. Modest fatigue. · Healthcare visit (other): Lab testongMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
-
2021-10-01
Dose 3 — Moderna
- 2021-10-23
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-05-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-09 | Moderna | |
| 3 | 2021-10-01 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 2 — day 14, dose 1
Symptoms: Flu-like symptoms for 5 days after vaccine, with generalized myalgia, fatigue, chills, some arthralgias, fatigue. Now fully resolved.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Except for the nausea, which is new, the signs and symptoms are similar to the first administration - just somewhat more severe. Also Raynauds and livido - more severe this morning than now.
Systemic reaction (other): Raynauds; livido reticularis. Improved since yesterday.
Release 8 — 3 months, dose 2
Symptoms: Continuing Raynauds and chillblains. Sicca syndrome. Modest fatigue.
Healthcare visit (other): Lab testong
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Laboratory test | ✓ | ✓ | ○ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Influenza like illness | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Raynaud's phenomenon | · | · | ✓ |
| SRO | Livedo reticularis | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Raynaud's phenomenon | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release